Nevro Corporation has received approval from the U.S. FDA for its Senza spinal cord stimulation (SCS) system for the treatment of chronic pain.
Pain management
St. Jude Medical Completes Acquisition of Spinal Modulation, Inc.
Try Turns to Buy as St. Jude slots Spinal Modulation’s Axium into its chronic pain portfolio
Retrospective Study Says Boston’s Spinal Cord Stimulator Works at 12 Months
Whatever the value of retrospective data, Boston Scientific is touting results that make a solid case for its Precision Spectra spinal cord stimulator system
First Ever Sham-Controlled Pain Management Neurostimulator Study
Stimwave’s pain management device can be programmed to reduce patient perception, making it possible to perform a sham-controlled study for the first time.
FDA Clears World’s First Injectable Wireless MicroSize Pain Relief System
Stimwave Technologies Inc., tells us it has received FDA clearance to market the world’s first wireless, microtechnology neuromodulation device for relief of chronic back and leg pain.
Miniaturized Ultrasound for Pain Makes International Debut at Medica 2014
sam claims to be the first device in a new technology category of ultrasound bio-electronics.
NeuroTherm Acquisition Broadens St. Jude’s Pain Management Portfolio
St. Jude Medical, Inc. is to acquire privately held NeuroTherm, Inc., a manufacturer of interventional pain management therapies, for approximately $200 million in cash.
Pain Management Company Zynex Pained by FDA’s Warning Letter
Zynex Medical doesn’t escape the sharp edge of the FDA’s tongue in a damning letter following January audit.
FDA Clearance for SpringTMS® Portable Migraine Treatment Device
With its new FDA clearance, SpringTMS becomes the first medical device available to patients in the United States to relieve the pain caused by migraine headaches that are preceded by an aura.
Another Back Pain Study Supports Boston’s Precision Spectra™ Spinal Cord Stimulator
New retrospective data presented at the World Institute of Pain (WIP) 7th World Congress demonstrates that Boston Scientific’s Precision Spectra™ Spinal Cord Stimulator (SCS) System provided sustained and highly significant relief of low-back pain six months after implantation.
St. Jude Claims “World First” as FDA Approves Upgradeable Spinal Cord Stimulator
St. Jude Medical, Inc., is trumpeting the U.S. FDA approval of its Protégé™ IPG, the first and only neurostimulation system that allows spinal cord stimulation (SCS) technology upgrades to be made via software updates.
CE Mark and EU Launch for St. Jude’s Prodigy Spinal Cord Stimulation System with Burst Technology
St. Jude Medical, Inc. has seen its Prodigy™ Chronic Pain System with Burst Technology gain CE Mark approval, which it says will be followed by European launch.
Improved NeuroMetrix SENSUS Device Launched
The last time we covered NeuroMetrix, Inc., it was the news that its SENSUS Pain Management System had become the first … continue reading “Improved NeuroMetrix SENSUS Device Launched”
FDA filing for eNeura’s SpringTMS® Migraine Treatment
eNeura Inc., a privately held medical technology company, has announced the filing of a 510(k) with the U.S. FDA for the SpringTMS® transcranial magnetic stimulation (TMS) device, a progression from its already approved CerenaTMS solution for migraine treatment.
FDA Clears Smiths Medical CADD®-Solis Pain Pump
Smiths Medical says its newly cleared CADD®-Solis pain management system combines Patient controlled and Programmed Intermittent Bolus deliveries for labor analgesia and post-operative pain management
Boston Scientific Reports Impressive Pain Relief Results for Precision Spectra™ Spinal Cord Stimulator
New retrospective data presented at NANS 2013 this week show highly significant reduction in pain and high trial therapy success rate of Boston Scientific’s Precision Spectra in the treatment of chronic pain